Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

WuXi AppTech Co-Founders Make $20 Million Gift for Cancer Research

Week in Review: BeiGene Cleared to Stage $3 Billion IPO on Shanghai STAR Exchange

China Expected to Approve Brii Bio COVID-19 Therapy Next Month

Week in Review: Zai Lab Announces Two In-Licensings with Total Value of $800 Million

Week in Review: Two China Affiliated Biopharmas Raise $585 Million in IPOs

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China